文献速递临床试验与 GCP

排卵女性冻胚移植前自然排卵方案与程序化方案对比:多中心随机临床试验

Natural ovulation versus programmed regimens before frozen embryo transfer in ovulatory women: multicentre, randomised clinical trial.
PubMed 文献 · BMJ · 2026-01-21

在中国24家生育中心纳入4376例排卵女性,随机接受自然排卵方案或程序化激素替代方案准备内膜后行单囊胚冻胚移植。自然排卵方案健康活产率与程序化方案无显著差异(41.6% vs 40.6%),但临床妊娠者中子痫前期风险更低,早期流产、胎盘植入谱系、剖宫产及产后出血发生率也更低,周期取消率更高。

要点

  • 自然排卵方案健康活产率41.6%与程序化方案40.6%无显著差异(RR 1.03,95%CI 0.96-1.10;P=0.49)。
  • 临床妊娠者中子痫前期风险自然排卵组2.9%低于程序化组4.6%(RR 0.63,95%CI 0.43-0.94;P=0.02)。
  • 自然排卵组周期取消率16.2%高于程序化组11.5%(P<0.001)。

核心结论

  • 在排卵女性中,冻胚移植前自然排卵方案准备内膜在获得健康活产方面与程序化方案等效,但妊娠期母体并发症风险更低。

研究设计与样本

  • 多中心、随机、平行组、评估者盲法临床试验,在中国24家学术生育中心开展。
  • 共纳入4376例计划行单囊胚冻胚移植的排卵女性(年龄20-40岁),按1:1随机分配。
  • 自然排卵方案组通过监测自然卵泡发育及血清促黄体生成素、雌二醇、孕酮水平确定内膜准备与移植时机;程序化方案组采用雌孕激素序贯给药准备内膜。
  • 主要结局为健康活产及冻胚移植后子痫前期或子痫;次要结局包括周期取消、生化妊娠、临床妊娠、持续妊娠、妊娠丢失、异位妊娠、活产、出生体重及母胎新生儿并发症。
  • 试验注册号:中国临床试验注册中心ChiCTR2200057990。

主要发现

  • 意向性分析中,自然排卵方案组2185例中910例(41.6%)获得健康活产,程序化方案组2191例中890例(40.6%)获得健康活产(相对比1.03,95%CI 0.96-1.10;P=0.49)。
  • 达到临床妊娠的患者中,自然排卵组子痫前期风险2.9%(38/1302)低于程序化组4.6%(61/1326)(相对比0.63,95%CI 0.43-0.94;P=0.02)。
  • 自然排卵组早期妊娠丢失12.1%(158/1302)低于程序化组15.2%(201/1326)(相对比0.80,95%CI 0.66-0.97)。
  • 自然排卵组胎盘植入谱系1.8%(24/1302)低于程序化组3.6%(48/1326)(相对比0.51,95%CI 0.31-0.83)。
  • 自然排卵组剖宫产69.5%(776/1117)低于程序化组75.6%(831/1100)(相对比0.92,95%CI 0.87-0.97);产后出血2.0%(22/1117)低于程序化组6.1%(67/1100)(相对比0.32,95%CI 0.20-0.52)。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the hypothesis that women assigned to a natural ovulation regimen before frozen embryo transfer compared with a programmed regimen would have an increased chance of a healthy live birth and a reduced risk of pre-eclampsia or eclampsia. DESIGN: Multicentre, randomised, parallel group, assessor blinded clinical trial. SETTING: 24 academic fertility centres in China. PARTICIPANTS: 4376 ovulatory women (aged 20-40 years) planning to undergo a frozen single blastocyst transfer. INTERVENTIONS: Eligible participants were randomised (1:1) to receive a natural ovulation regimen or a programmed regimen of hormone replacement for endometrial preparation. Endometrial preparation and frozen embryo transfer timing were determined in the natural ovulation regimen group by monitoring natural follicle development and measuring serum levels of luteinising hormone, oestradiol, and progesterone. In the programmed regimen group, endometrial preparation was achieved by sequential administration of oestrogen and progesterone. MAIN OUTCOMES AND MEASURES: Primary outcomes were a healthy live birth and pre-eclampsia or eclampsia after a frozen embryo transfer. Secondary outcomes were cycle cancellation, biochemical pregnancy, clinical pregnancy, ongoing pregnancy, pregnancy loss, ectopic pregnancy, live birth, birth weight, and maternal, fetal, and neonatal complications. RESULTS: In the intention-to-treat analyses, 910 (41.6%) of 2185 patients in the natural ovulation regimen group and 890 (40.6%) of 2191 in the programmed regimen group achieved a healthy live birth (relative ratio 1.03 (95% confidence interval (CI) 0.96 to 1.10); P=0.49). The risk of pre-eclampsia was lower in the natural ovulation regimen group among patients who achieved clinical pregnancy than in the programmed regimen group (2.9% (38 of 1302) v 4.6% (61 of 1326); 0.63 (0.43 to 0.94); P=0.02). The incidences of early pregnancy loss (12.1% (158 of 1302) v 15.2% (201 of 1326); 0.80 (0.66 to 0.97)), placental accreta spectrum (1.8% (24 of 1302) v 3.6% (48 of 1326); 0.51 (0.31 to 0.83)), caesarean section (69.5% (776 of 1117) v 75.6% (831 of 1100); 0.92 (0.87 to 0.97)), and postpartum haemorrhage (2.0% (22 of 1117) v 6.1% (67 of 1100); 0.32 (0.20 to 0.52)) were lower in the natural ovulation regimen group. No differences between groups were observed for birth weight or neonatal complications. The rate of cycle cancellation was higher in the natural ovulation regimen (16.2% (354 of 2185) v 11.5% (251 of 2191), P<0.001). The prespecified per protocol and subgroup analyses yielded results consistent with the intention-to-treat analyses. CONCLUSIONS: In ovulatory women, a natural ovulation regimen for endometrial preparation was as effective as programmed regimen in terms of achieving a healthy live birth after frozen embryo transfer, but with a lower risk of maternal complications during pregnancy. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2200057990.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Wei D, Qin Y, Sun Y, et al. Natural ovulation versus programmed regimens before frozen embryo transfer in ovulatory women: multicentre, randomised clinical trial. BMJ. 2026. PMID: 41565309. doi:10.1136/bmj-2025-087045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。